MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-14-2025
bluebird bio PEG Ratio 2011-2026 | BLUE
Annual PEG Ratio bluebird bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0148 | 0.295 | -0.0561 | -0.103 | 0.169 | 0.316 | 2.92 | 0.207 | 0.0528 | -5.38 | 0.117 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.92 | -5.38 | -0.132 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M |  USA |
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
0.0951 | $ 0.89 | 1.48 % | $ 6.54 M | China |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.2 | -2.07 % | $ 3.68 B | USA |
 |
Evogene Ltd.
EVGN
|
-1.63 | $ 0.75 | -4.66 % | $ 27.9 M |  Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | USA |
 |
Galapagos NV
GLPG
|
0.0003 | $ 27.86 | -1.97 % | $ 2.69 B |  Belgium |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | USA |
 |
ImmuCell Corporation
ICCC
|
0.153 | $ 8.44 | 1.08 % | $ 76.2 M | USA |
 |
Innoviva
INVA
|
0.012 | $ 23.05 | -2.7 % | $ 1.55 B | USA |
 |
Innate Pharma S.A.
IPHA
|
-0.0174 | $ 1.49 | 6.43 % | $ 235 M | France |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Jaguar Health
JAGX
|
-0.000005 | $ 0.23 | -6.64 % | $ 536 K | USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-7.82 | - | 17.91 % | $ 11.1 M | USA |
 |
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
-12.8 | $ 101.57 | -0.48 % | $ 27.2 B | Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | USA |
 |
Kamada Ltd.
KMDA
|
1.39 | $ 8.11 | -0.49 % | $ 260 M | Israel |
 |
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.05 | -0.98 % | $ 433 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 22.37 | -3.95 % | $ 2.85 B | USA |
 |
Fennec Pharmaceuticals
FENC
|
0.178 | $ 6.26 | -6.57 % | $ 179 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.41 | -4.73 % | $ 375 M | Britain |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 2.98 | 2.41 % | $ 4.91 M | Israel |
 |
Madrigal Pharmaceuticals
MDGL
|
-9.96 | $ 518.58 | 0.37 % | $ 11.6 B | USA |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |